Literature DB >> 16019094

Epidemic and endemic Kaposi's sarcoma: a comparison of outcomes and survival after radiotherapy.

Joseph B Kigula-Mugambe1, Awusi Kavuma.   

Abstract

We retrospectively studied the outcomes of 80 Epidemic and African-Endemic Kaposi's Sarcoma (EKS and AKS) patients treated with radiotherapy doses of 8.0 Gy. The objective response for EKS at one month was 74 and 58% for AKS while 5-year survival for EKS was 27 and 46% for AKS.

Entities:  

Mesh：

Year:  2005        PMID： 16019094     DOI： 10.1016/j.radonc.2005.06.008

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  3 in total

1.  Radiotherapy in the management of Kaposi's sarcoma: comparison of 8 Gy versus 6 Gy.

Authors:  Ferah Yildiz; Mine Genc; Serap Akyurek; Mustafa Cengiz; Enis Ozyar; Ugur Selek; I Lale Atahan
Journal:  J Natl Med Assoc       Date:  2006-07       Impact factor: 1.798

Review 2.  Liposomal daunorubicin as treatment for Kaposi's sarcoma.

Authors:  Christin E Petre; Dirk P Dittmer
Journal:  Int J Nanomedicine       Date:  2007

3.  Mucosal Kaposi sarcoma, a Rare Cancer Network study.

Authors:  Juliette Thariat; Youlia Kirova; Terence Sio; Olivier Choussy; Hans Vees; Ulrich Schick; Gilles Poissonnet; Esma Saada; Antoine Thyss; Robert C Miller
Journal:  Rare Tumors       Date:  2012-10-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.